Abstract
Objective: To motivate prenatal care staff in public and private settings to universally screen for risk of alcohol and drug use and to conduct a brief intervention with follow-up referral when appropriate during a routine office visit. Methods: The ASAP Project methods were engagement of site staff; staff training; self-administered questionnaires embedded with a relational and broad catch screening tool; a brief intervention protocol; unique clinical decision tree/protocols for each site; identification of treatment and referral resources; and ongoing technical assistance and consultation. Sites were located in four regions of the state and included four community health centers, a network of multi-specialty private practices and a teaching hospital. Results: Across 16 sites, 118 prenatal staff were trained on use of the screening tool and 175 staff on the brief intervention. The ASAP Project resulted in 95% of pregnant women being screened for alcohol use and 77% of those screening positive for at least one risk factor receiving a brief intervention during a routine office visit. Conclusions: Screening and brief interventions for alcohol use can be delivered effectively within a routine prenatal care visit by prenatal staff by utilizing and building on existing office systems with practice staff, screening for any use not only at risk use, providing training with skills building sessions and information delivered by physicians, offering easy-to-access community treatment resources, and providing ongoing technical assistance.
Similar content being viewed by others
REFERENCES
Day NL, Leech SL, Richardson GA, Cornelius MD, Robles N, Larkby C. Prenatal alcohol exposure predicts continued deficits in offspring size at 14 years of age. Alcohol Clin Exp. Res 2002;26(10):1584–91.
Mattson SN, Schoenfeld AM, Riley EP. Teratogenic effects of alcohol on brain and behavior. Alcohol Res Health 2001;25(3):185–91.
Morse B, Hutchins E. Reducing complications from alcohol use during pregnancy through screening. JAMWA 2000 Summer; 55(4):225–7, 240.
Mick E. Smoking and Alcohol in Pregnancy: Dr. Mick replies. J Am Acad Child Adolesc Psychiatry December2002;41(12):1392.
Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt D. Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 2002;24(3):309–20.
Zuckerman B, Bresnahan K. Developmental and behavioral consequences of prenatal drug and alcohol exposure. Pediatr Clini North Am 1991;38(6):1387–406.
FriedmannPD, McCulloughDM, ChinMH, Saitz R. Screening and intervention for alcohol problems: A national survey of primary care physicians and psychiatrists. J Gen Intern Med 2000;15:84–91.
Frank DA, Zuckerman BS, Amaro H, Aboagye K, Bauchner H, Cabral H, Fried L, Hingson R, Kayne H, Levenson SM. Cocaine use during pregnancy: Prevalence and correlates. Pediatrics 1988 Dec;82(6):888–95.
SchutzmanDL, Frankenfield-ChernicoffM, ClatterbaughHE, Singer J. Incidence of intrauterine cocaine exposure in a suburban setting. Pediatrics 1991 Oct;88(4):825–7.
MorseB, Greshan S, Hutchins E. Screening for substance abuse during pregnancy: Improving care, improving health.Arlington, VA: National Center for Education in Maternal and Child Health, 1997.
Roche AM, Richard GP. Doctors willingness to intervene in patient's drug and alcohol problems. Soc Sci Med 1991;33:1053–61.
Howell E, HeisnerN, ThorntonC, Moreno L, Chasnoff I.Third annual report: Evaluation of the demonstration to improve access to care for pregnant substance abusers. Washington, DC: Mathematica Policy Research, Inc; 1996.
Arndt S, Schultz SK, TurveyC, Peterson A. Screening for alcoholism in the primary care setting: Are we talking to the right people? J Fam Pract 2002;51(1):41–6.
The National Center on Addiction and Substance Abuse (CASA). Missed opportunity: National survey of primary care physicians and patients on substance abuse. New York: Columbia University, 2000.
Hack MR, Alemi F. Medicaid reimbursement of primary care providers for treatment of substance abuse disorders. In: Hack MR, Adger H, Jr. Strategic plan for interdisciplinary faculty development: Arming the nation's health professional workforce for a new approach to substance use disorders. Providence, RI: Association for Medical Education and Research in Substance Abuse (AMERSA), 2002:95–104.
Saitz R, Mulvey KP, Plough A. Physician unawareness of serious substance abuse. Am J Med Drug Alcohol Abuse 1997;23(3):343–54.
Caldwell D, Burke N. Maternal Substance Use Assessment Methods Reference Manual: A review of screening and clinical assessment instruments for examining maternal use of alcohol, tobacco, and other drugs.Rockville,MD:U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Preventiion, 19963. (CSAP Special Report 13).
Chasnoff I, Neuman K, Thornton C, Callaghan A. Screening for substance use in pregnancy: A practical approach for the primary care physician.AmJ Obstet Gynecol 2001;184(4):752–8.
Tuten LM, Robilotto CM, Jones HE, Lantz M, Svikis DS. Alcohol, drug use and other health behaviors in pregnant smokers and non-smokers.Baltimore,MD: John Hopkins School of Medicine, 2000.
Kahn RS, Certain L, WhitakerRC.Are-examination of smoking before, during and after pregnancy. Am J Public Health 2002;92(11):1801–8.
Svikis D, Henningfield J, Gazaway P, Huggins G, Sosnow K, Hranicka J, Harrow C, Pickens R. Tobacco use for identifying pregnant women at risk of substance abuse. J Reprod Med 1997;42:299–302.
Hutchins E, DiPietro, J. Psychosocial risk factors associated with cocaine use during pregnancy: A case-control study. Obstet Gynecol 1997;90(1):142–7.
National Institute on Alcohol Abuse and Alcoholism. Physicians' guide to helping patients with alcohol problems. Washington, DC: National Institutes of Health PublicationNo. 95-3769, 1995.
Laken MP, Hutchins E. Recruitment and retention of substance-using pregnant and parenting women: Lessons learned. Arlington,VA: National Center for Education in Maternal and Child Health, 1996.
ChangG. Alcohol-screening instruments for pregnant women. Alcohol Res Health 2001;25(3):204–9.
Foa EB, Cashman L, Jaycox L, Perry K. The validation of a self-report measure of posttraumatic stress disorder: The posttraumatic diagnostic scale. Psychol Assess 1997;9(4):445–51.
NHP/Beacon Behavioral Health Program (1998). Pediatric Screening Guideline Draft, Boston, MA: Beacon Health Strategies.
Tourangeau R, SmithTW.Asking sensitive questions: The impact of data collection mode, question format and question context. Public Opin Q 1996;60:275–304.
Aquilino WS. Interview mode effects in surveys of drug and alcohol use. Public Opin Q 1994;58:210–40.
Center for Substance Abuse Prevention (CSAP), Division of Demonstrations for High-Risk Populations. Maternal substance use assessment methods reference manual: A review of screening and clinical assessment instruments for examining maternal use of alcohol, tobacco, and other drugs: CSAP special report 13. Washington, DC: U.S. Government Printing Office, 1993. DHHS Publication No. SMA 93-2059.
Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 1986;124:986–99.
MacGregor SN, Keith LG, Chasnoff IJ, Rosner MA, Chisum GM, Shaw P, Minogue JP. Cocaine use during pregnancy: Adverse perinatal outcome: Adverse perinata outcoum. Am J Obstet Gynecol 1987;157:686–690.
Shiono PH, Klebanoff MA, Nugent RP, Cotch MF, Wilkins DG, Rollins DE, Carey JC, Behrman RE. The impact of cocaine and marijuana use on low birth weight and preterm birth: Amulticenter study.AmJObstet Gynecol 1995;172(1, Pt 1):19–27.
ZuckermanB, FrankDA, Hingson R, AmaroH, LevensonSM, Kayne H, Parker S, Vinci R, Aboagye K, Fried LE, Cabral H, Timperi R, Bauchner H. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989;320:762–8.
Streisguth AP, Sampson P, Barr H. Neurobehavioral doseresponse effects of prenatal alcohol exposure in humans from infancy to adulthood. Ann NY Acad Sci 1989;562:145–58.
Chasnoff IJ, Anson A, Hatcher R, Stenson H, Iaukea K, Randolph L. Prenatal exposure to cocaine and other drugs: Outcome at four to six years. In: Harvey JA, Kosofsky BE, editors. Cocaine effects on developing the brain.New York: Annals of the New York Academy of Sciences, 1998:314–28.
Little RE, Youth A, Streissguth AP, Uhl CN. Prevention of fetal alcohol effects: Effectiveness of a demonstration project. In: R. Porter, M. O'Connor, and J. Whelan (Eds.), CIBA Foundation Symposium 105: Mechanisms of alcohol damage in utero, (London: Pitman 1984), pp. 2524–74.
Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy: Perinatal outcome. JAMA 1989;161:1741–4.
Fleming MF, Barry KL, Manwell LB, Johnson K, London R. Brief physician advice for problem drinkers: A randomized controlled trial in community-based primary care practices. JAMA 1997;277(13):1039–45.
Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: A meta-analytic review of controlled investigations in treatment-seeking and non-treatment seeking populations. Addiction 2002;97:279–92.
Samet JH, Rollnick S, Barnes H. Beyond CAGE:Abrief clinical approach after detection of substance abuse. Arch Int Med 1996;156(20):2287–93.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kennedy, C., Finkelstein, N., Hutchins, E. et al. Improving Screening for Alcohol Use During Pregnancy: The Massachusetts ASAP Program. Matern Child Health J 8, 137–147 (2004). https://doi.org/10.1023/B:MACI.0000037647.78420.e3
Issue Date:
DOI: https://doi.org/10.1023/B:MACI.0000037647.78420.e3